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Abstract
Aim—To determine the relationship between quality of life (QoL) and perceived self reported
symptoms in an elderly, ambulatory, urban population living with heart failure (HF).
Background—While arrhythmias in the elderly with HF are well documented, the association
between perceived arrhythmia symptoms and QoL is not well defined.
Design—Prospective, cross sectional single center study.
Methods—A single-center, prospective study was conducted with HF patients recruited from an
urban outpatient cardiology clinic in the United States. Fifty-seven patients completed a baseline
QoL survey with 42 of these completing the 6-month follow-up survey. QoL was evaluated with
the SF-36v2™ and frequency of symptoms with the Atrial Fibrillation Severity Scale. Subjects
wore an auto triggered cardiac loop monitor (LifeStar AF Express®) for 2-weeks to document
arrhythmias. Data analysis utilized Spearman’s rank correlation and logistic regression.
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Results—Baseline and 6-month QoL measures did not correlate with recorded arrhythmias.
However, perceptions of diminished general health correlated significantly with symptoms of
exercise intolerance, lightheadedness/dizziness, palpitations, and chest pain/pressure. By
multivariable logistic regression, more severe perceived arrhythmic, symptoms of exercise
intolerance, and lightheadedness/dizziness were independently associated with diminished QoL.
Conclusion—QoL was significantly worse in patients with perceptions of severe arrhythmic
episodes and in those whose symptoms of dizziness and exercise intolerance.
Relevance to clinical practice—The findings of this study indicate that symptomatic HF
patients suffer from poor QoL and that interventions are needed to improve QoL and decrease
symptom severity. Nurses who care for HF patients play an essential role in symptom evaluation
and management and could significantly improve overall QoL in these patients by carefully
evaluating symptomatology and testing interventions and educational programs aimed at
improving QoL.
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Introduction
Individuals 65 years of age or older are living longer but with a variety of chronic diseases
including heart failure (HF) (Fuster et al., 2006; Hunt et al., 2005). Those with HF
commonly reported symptoms of fatigue, dyspnea (Carlson et al., 2001; De Peuter et al.,
2004; Ramasamy et al., 2006) and exercise intolerance (Hunt et al., 2005). However, these
symptoms can also exist in people experiencing an atrial or ventricular arrhythmia (Dorian
et al., 2000; Francis et al., 2010; Hickey et al., 2010). Regardless of the underlying cause,
HF and isolated arrhythmias (atrial and ventricular ectopy) can result in significant
symptoms, which can impact quality of life (QoL). To date, the relationship of perceived
symptoms to QoL in the elderly remains poorly investigated, especially in urban Latinos
living with HF and other cardiovascular disease.
Background
One of the consequences of aging is the increasing prevalence of chronic diseases (Bayliss
et al., 2004). Among these, heart failure (HF) has become one of the most prevalent diseases
in the elderly, and this will continue to increase in the coming decades as the aging
population lives longer (Jaagosild et al., 1998; Jaarsma et al., 1999) and the baby boomer
population continues to age. Nearly 90% of patients with HF experience symptoms such as
dyspnea and fatigue (Edmonds et al., 2005; Evangelista et al., 2008; Falk et al., 2007)and
emotional symptoms like depression, anxiety and uncertainty (Evangelista et al., 2008; Heo
et al., 2008; Moser et al., 2010). Thus, diagnosing symptoms related to HF vs. an underlying
arrhythmia can be very difficult because of changes in sensory and symptom perception, and
hearing, memory and comprehension losses, coupled with emotional symptoms and poor
functional status which also become more common with advancing aging (Bayliss et al.,
2004; Carlson et al., 2001; Heo et al., 2007). This further underscores the challenges for
clinicians on how to best delineate whether reported symptoms are from a chronic
cardiovascular condition such as HF or a potentially life-threatening arrhythmia. Since
individual symptoms vary greatly in intensity, duration, and frequency from day to day,
documentation and evaluation is especially difficult. In fact, some elderly patients may not
be aware of subtle changes in their physical and mental well-being and may not report
symptoms to their practitioners unless specifically asked. Others may simply forget to report
symptoms experienced between routine follow up exams, or may attribute symptoms to
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aging. Thus, further evaluation e.g., cardiac monitoring, or other diagnostic testing is not
conducted. In this population, we previously reported that external cardiac monitoring was
able to detect significant cardiac events that would have otherwise gone undetected and lead
to appropriate cardiac treatment with either a pacemaker or implantable cardioverter
defibrillator (ICD) (Hickey et al., 2010). Thirty percent of subjects with HF reported
symptoms while wearing an external cardiac monitor that were most frequently correlated
with isolated atrial and ventricular premature ectopic beats, non-sustained ventricular
tachycardia, and AV block (Hickey et al., 2010). Although recognition of arrhythmias that
require treatment is of paramount importance, symptom differentiation in the elderly takes
on a vital role.Evaluating health-related quality of life and the impact of perceived symptoms
becomes more critical in the elderly living with chronic cardiovascular diseases to determine
the origin of such symptoms and to better understand the impact on QoL among elderly
individuals suffering from multiple chronic diseases.
Health related QoL is a general concept that is often used to describe ones overall well
being, as subjective and multidimensional, including physical, psychological and social
dimensions. The options for the measurement tool should be based on the aims of the study
and on the availability of the instrument (developed or culturally adapted) for the target
population. Analysis of the psychometric properties of an instrument is critical for
evaluating its reliability and the QoL dimensions for specific groups, like the elderly
(Johansson et al., 2004; McHorney et al., 1994; Ware et al., 2007). Among the instruments
for HF that are currently used, the Short-Form Health Survey (SF-36) is one of the most
frequently applied generic instruments for adult populations (Bayliss et al., 2004; Johansson
et al., 2004; Ware et al., 2007).
In addition, the components of the instrument should be clear, the population and the disease
for which the measurement was developed should be defined, and the instrument has to be
simple and straightforward, such that the time taken to administer it is appropriate
(Jenkinson et al., 1997; McHorney et al., 1994; Ware et al., 2007).
This study utilized the SF-36 because of its established reliability and validity,
straightforward and simple questions, and previous use in elderly populations (Peek et al.,
2004; Jang et al., 2009). The goal of this study was to determine the relationship between
QoL and perceived self reported symptoms commonly experienced in an elderly,
ambulatory, urban population living with HF, and other cardiovascular risk factors (e.g.,
hypertension, diabetes, hyperlipidemia, and smoking). For this purpose, assessments of QoL
and associated self-reported symptoms at baseline (prior to cardiac monitoring) were
captured with the SF 36 initially and again at 6 months for comparisons.
Methods
Design
A prospective, cross sectional study was conducted to determine the association between
self-reported symptoms and QoL assessments. Subjects were asked to wear the LifeStar AF
Express® (LifeWatch, Inc.), an auto-triggered external memory-loop EKG recorder, for 14
days and transmit EKG strips daily via their home phone line in order to document the
frequency and duration of arrhythmias, both silent and symptomatic. In addition, subjects
were requested to press an event recorder button on the monitor when symptomatic and to
record any associated symptoms in a free-form text diary similar to what is used in clinical
practice. Overall QoL and symptoms were assessed prior to wearing the cardiac event
monitor for a period of two weeks. Two previously validated instruments were used: the
SF-36v2™ and the University of Toronto Atrial Fibrillation Severity Scale (AFSS). QoL
was measured by the SF-36v2™ and symptoms were assessed using the AFSS. Although the
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AFSS has been developed and used in the detection of associated symptoms in those with
atrial fibrillation, we employed it in this study because symptoms of arrhythmias and heart
failure have been reported to be similar (e.g., fatigue and dyspnea) (Dorian et al., 2002;
Francis et al., 2010; Fuster et al., 2001).
Subjects
A convenience sample of subjects was recruited from the outpatient cardiac clinic at New
York-Presbyterian Hospital. Inclusion criteria for study participation were: (1) age 65 years
or older, and (2) a history of HF documented in their medical chart by their primary
cardiologist. Exclusion criteria were: (1) a recent cardiac event (myocardial infarction,
stroke) in the month prior to enrollment; (2) a prior pacemaker or ICD implant; or (3) a
history of documented atrial fibrillation or ventricular or bradycardiac arrhythmias.
Power calculations indicated that a sample size of 46 was required to have 80% power at a
0.05 significance level to detect an association with a correlation coefficient of magnitude
0.40 or greater.
Ethical Considerations
Approval for the study was obtained from the Columbia University Institutional Review
Board and informed consent was obtained from all subjects prior to participation. The
purpose of the study and procedures to be used were explained to the subjects and they were
informed that their participation was voluntary. They were told that that the study data
would be kept confidential with the results being reported only in aggregate and that there
would be no consequences for refusing to participate.
Measures
The SF-36v2™ is a multi-item scale that measures QoL and 8 health concepts (4 physical
and 4 mental health domains) rated on a 3- to 6-point Likert scale (Ware et al., 2007) with
documented validity and reliability when used in elderly white and minority populations
(Peek et al., 2004; Jang et al., 2009). This instrument queries an individual about activities,
perceptions, and limitations in a typical day within the last 4 weeks and compared to one
year ago. This validated QoL tool has been used in a variety of AF clinical trials
(Lonnerholm et al., 2000; Newman et al., 2003; Savelieva et al., 2001). Responses to the
SF-36v2™ QoL questionnaire were transformed into norm-based scores. The 4 physical
domains (physical functioning, role-physical, bodily pain, general health) and 4 mental
health domains (vitality, social functioning, role-emotional, and mental health) were
determined along with the physical component summary (PCS) and mental component
summary (MCS) scores. These measures are scaled to have a mean of 50 and a standard
deviation of 10 in the general population (Ware et al., 2007). Patients with heart disease
typically have lower than average PCS scores (Ware et al., 2007). The response to question
1, characterizing general health as excellent, very good, good, fair, or poor, was used as the
primary outcome measure of QoL. Responses to this question have been used as the “gold
standard” for assessing criterion validity for other dimensions of the SF-36 (Jenkinson et al.,
1994).
The AFSS is a 14-item disease-specific scale developed to capture subjective and objective
ratings of AF disease burden, including frequency, duration, and severity of subjectively
perceived episodes (Dorian et al., 2002; Maglio, 1998). The most recent version of the
AFSS also includes an abbreviated version of the AF Symptoms Checklist (Bubien et al.,
1996). This scale has been used successfully in large clinical trials, including the Canadian
Trial of Atrial Fibrillation in which patients with paroxysmal or persistent AF who were
treated with antiarrhythmic drug therapy reported higher (better) scores of global well-being
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at 3 months as compared to baseline (Dorian et al., 2002). The AFSS documents the severity
of symptoms during the past 4 weeks on a scale of 0 to 5 including: palpitations, shortness
of breath at rest, shortness of breath during physical activity, exercise intolerance defined as
fatigue during mild physical activity, fatigue at rest, lightheadedness or dizziness, and chest
pain or pressure. A score of 0 denotes a complete lack of symptoms while a score of 5
indicates that the symptom is present a great deal of the time. Severity of the most recent
episode of irregular heart rhythm on a scale of 1 to 10 was also recorded. Patients who did
not experience any episodes of irregular heart rhythm were assigned a score of 1. In
addition, the AFSS also collected information on visits to doctors and hospital emergency
rooms during the preceding 4 weeks.
Cardiac monitoring
All subjects were given a LifeStar AF Express® monitor to wear for 14 days along with
instructions in English or Spanish on how to transmit data from their device over the phone
to a central receiving service for analysis. A 2-week monitoring period was chosen as a
modest and tolerable period for continuous ambulatory outpatient ECG monitoring in an
older population that may not be technologically savvy. This time frame is longer than
standard Holter monitoring (24 hours) yet shorter than most cardiac event monitors (3-4
weeks) and was felt to be achievable in a “real world” environment.
Subjects were instructed to transmit at least once daily, as well as any time they experienced
any symptoms. Daily compliance rate for transmission was 79% for the 2-week period and
all symptoms were captured at the time of transmission by a cardiac technician who assisted
patients with transmission over the phone. Seventy-eight percent of subjects recorded the
presence or absence of symptoms in their daily diary. However, all subjects reported to the
staff at LifeWatch, Inc. (via telephone) whether or not they had experienced symptoms just
prior to their daily transmission. This data was used to correlate symptoms related to
arrhythmia with findings on the external cardiac devices.
Cardiac monitoring documented one episode of atrial fibrillation in a female patient who
was symptomatic while wearing the monitor for whom therapy was later begun
(anticoagulation). In addition, 2 subjects had 4 to 6 beat runs of self-terminating ventricular
tachycardia that contributed to a decision to implant an ICD for primary prevention of
sudden cardiac death. Four subjects underwent permanent pacemaker placement for severe
bradycardia: one for a prolonged pause, and the other 3 individuals for advanced AV block
captured during the monitoring period. Therefore, in 7/57 subjects (12%), a significant,
otherwise unanticipated dysrhythmia of clinical importance was detected during the two
week monitoring period
Statistical analysis
Clinical data are reported as means and standard deviations for continuous variables and as
frequencies for categorical variables. Correlations between QoL measures and severity of
symptoms were determined using Spearman’s rank correlation. Multivariable logistic
regression was used to determine the relationship between the primary QoL assessment of
general health, dichotomized as fair/poor and good/very good/excellent, and clinical
variables and symptom severity. For this analysis, symptom severity was dichotomized as
0-1 (none or very little) vs. 2- 5 corresponding to greater severity of symptoms. The overall
severity of the last irregular heart rhythm was dichotomized as ≤ 4 or > 4, corresponding to
the 75th percentile of the distribution for this variable. All variables that were significantly
correlated with general health were considered as candidates with variable selection being
performed using a stepwise procedure with a p-value of 0.05 as inclusion criterion. The
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significance of changes over time in QoL measures was assessed by paired t-test. A p-value
of 0.05 was used for significance in all analyses.
Results
Sixty-three ambulatory patients with chronic stable systolic HF (class II to III) from a
primarily minority, Medicare population seen in an urban cardiac clinic of New York City
were enrolled and followed in the study from 2005-2009 (Figure 1). Fifty-seven of these
(90%) completed the baseline QoL determination and are the subject of this report.
Incomplete questionnaires that lacked responses to general health questions were received
from 5 of the enrolled patients who were excluded from the study. Forty-eight of the 57
patients who completed the baseline questionnaire (84%) had recorded symptoms
documented by the LifeStar AF Express® and were transmitted to LifeWatch, Inc. Overall
QoL and symptoms were assessed prior to wearing the cardiac event monitor for a period of
two weeks. Forty-two out of the 57 patients (74%) completed their 6-month follow-up
where QoL was again measured. The 15 patients who did not complete their 6-month follow
up were unable to be reached via telephone, or were noted as being out of the country
(Dominican Republic) and had not returned to the clinic for their previously scheduled 6-
month follow up visit. The demographic and clinical characteristics and baseline QoL scores
between those who completed and did not complete their 6-month outpatient cardiac care
visit with their primary provider were not significantly different, nor were their cardiac
event rates on long term follow up. The characteristics of the patient population are
presented in Table 1. Cardiac monitoring data revealed 75% experienced ectopic activity,
and 31% were symptomatic including 10% with palpitations and 8% with dizziness. There
was no significant difference between the self-reported symptoms at baseline and the 6-
month follow-up visit.
Self-Reported Symptoms on the AFSS
From the AFSS questionnaire, 23% of patients reported having visited an emergency room
and 52% reported seeing their MDs in the 4 weeks prior to the baseline symptom
assessments. In addition, during that 4 week period 78% reported fatigue with mild exercise,
74% shortness of breath with exercise, 59% resting fatigue, 52% palpitations, 54% resting
shortness of breath, and 45% chest pain/pressure.
4.2. Self-Reported Symptoms on the SF-36v2™—On the baseline SF-36v2™ QoL
questionnaire, 1 patient (2%) reported their general health as excellent, 4 (7%) as very good,
23 (40%) as good, 27 (47%) as fair, and 2 (4%) as poor. Baseline assessments of general
health were significantly correlated with the severity of fatigue at rest (r=0.37, p= 0.008),
exercise intolerance (r=0.48, p = 0.0005), lightheadedness/dizziness (r=0.57, p < 0.0001),
palpitations (r=0.37, p = 0.008), and chest pain/pressure (r=0.44, p = 0.001), as represented
in Figure 2, but was not related to sustained arrhythmic events recorded during the
subsequent cardiac monitoring. The norm-based scores for the SF-36v2™ QoL
questionnaire are shown in Table 2. PCS averaged 40.82 while MCS averaged 43.40, values
typical for patients with heart disease (Ware et al., 2007). All domains were below the value
of 50 expected for the general population as well as for randomly selected individuals of
similar age (Peek et al., 2004; Jang et al., 2009). Fatigue at rest and exercise intolerance
were significantly correlated with PCS and MCS scores, as represented in Figures 3 and 4,
but did not correlate significantly with recorded arrhythmias on cardiac monitoring.
Univariate and multivariable logistic regression analysis was performed to determine which
clinical variables and symptoms were independently related to perceptions of general health
(Table 3). Variables significantly related to general health in the multivariable analysis
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included exercise intolerance (odds ratio = 7.7, 95% CI 1.1-51.9, p = 0.02), lightheadedness/
dizziness (odds ratio = 23.6, 95% CI 2.2-251, p = 0.0002), and severity of the last irregular
heart rhythm (odds ratio = 16.4, 95% CI 1.7-156, p = 0.01).
Responses to the SF-36v2™ questionnaire were collected on 42 individuals at the time of
their 6 month clinic follow up. No significant changes were observed in any of the
individual domains or summary scores, and there were no significant differences between
patients who did and did not demonstrate ectopic activity during cardiac monitoring. PCS
decreased slightly from 40.7 ±10.0 to 39.3 ± 9.3 while MCS increased slightly from 42.3 ±
14.4 to 43.4 ± 14.2.
Discussion
HF is a chronic and progressive disease, in which lower QoL is associated with worse
clinical outcomes, including high rates of hospital readmission and mortality. Our results
found the overall QoL of this primarily Latino, elderly urban population living with HF was
decreased, as compared with the general population, in all domains except vitality; high
scores for pep offset diminished scores for amount of energy, feelings of being worn out,
and tiredness in the vitality domain. Perceived general health status was significantly
correlated with the severity of fatigue at rest, exercise intolerance, lightheadedness/
dizziness, palpitations, and chest pain/pressure, and did not change in either the physical or
mental domain over a 6-month interval, emphasizing the chronic status of these symptoms
over time. Patients who perceived their arrhythmic episodes prior to cardiac monitoring to
be more severe as well as those with reported symptoms of dizziness and exercise
intolerance were more likely to perceive their QoL fair or poor. Limited research exists in
the literature in regards to older adults living in the community living with HF (Hayes et al.,
1995). However, our findings are similar to M. Gott, et al. who found a decreased QoL in
the elderly with HF living in a community setting (Gott et al., 2006). In addition, this
research identified those over 60 years with two or more co-morbidities as having the
poorest QoL (Gott et al., 2006). Our findings are similar; all subjects in our investigation
were over 65 years, with systolic HF and multiple other underlying co-morbidities such as
hypertension, diabetes and hyperlipidemia. In addition, these researchers reported that
women living with HF in the community had a worse, QoL as compared to men (Friedman
and King, 1995; Gott et al., 2006). This is generally consistent with our findings, where 60%
of our participants were women living in an urban community, who had both poor physical
and mental QoL. While no significant differences between men and women were observed
in baseline PCS and MCS scores, male gender was related to better perceptions of general
health in the univariate logistic regression analysis. This is consistent with previous research
that showed men with a better emotional functioning had a better QoL (Corvera-Tindel et
al., 2009).
With regard to frequently reported symptoms such as fatigue and shortness of breath, these
have been reported by other investigators as having a significant impact on overall QoL
(Evangelista et al., 2008; Heo et al., 2007; Moser et al., 2010). In contrast to these studies,
this work focused on the elderly with HF in a non-hospital setting, which is very different
from previously completed clinical trials that have excluded this patient population. In
clinical practice it has been observed that non-pharmacological interventions improve
patients’ physical symptoms and their functional capacity, yet in an ambulatory outpatient
population living with several chronic disease data is lacking on interventions in urban
elderly dwellers. Therefore, the present study suggests that strategies for improving HF
patients’ physical and mental condition need to be initiated and evaluated in regards to their
impact on QoL. Recently completed work by Lewis and Riegel also identified older
hypertensive adults living with chronic illnesses as having worse perceived health and
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outcomes, which is similar to our findings, as 95% of our subjects also had underlying HTN
(Lewis and Riegel, 2010).
The majority of patients served by our outpatient cardiac clinic are immigrants with a high
school education or less. Lower educational attainment has been correlated with worse
physical and functional conditions (Barbareschi et al., 2011). Since our elderly clinic
population is known to be of a low socioeconomic status and this may further account not
only the poorer health habits but higher levels of cardiac risk factors seen, in this HF
population. Our findings are similar to others showing that fewer resources, lower literacy,
lower socioeconomic status, and perceived control were associated with lower HF
knowledge, and self care behaviors and a worse QoL (Doering et al., 2010; Macabasco-
O’Connell et al., 2008; Macabasco-O’Connell et al., 2011).
This research examined an elderly outpatient urban population living with HF and identified
symptoms and their associated impact on QoL. This research adds to the literature by
examining HF and the association to perceived self-reported symptoms.
Replication of this study using a larger sample and involving other diverse ambulatory
settings where elderly reside will serve to better understand QoL. In addition, more
knowledge may be regenerated by using a qualitative approach in identifying factors
impacting QoL of elderly HF patients with multiple chronic diseases (diabetes,
hypertension, CAD) experiencing symptoms that likely include many origins that can
impact on QoL. Examining Latinos and other minorities using measures adapted to their
native language will further illuminate specific issues and ensure that information captured
is done so in the correct cultural context.
Conclusions
The need for appropriate educational interventions aimed at helping to identify symptoms
related to HF vs. an underlying arrhythmia is necessary. Detailed demographic and
economic data should be collected and examined in future studies along with depression and
anxiety measures since these may also have great influences on an individual’s perception of
both symptoms and overall QoL. Analyzing QoL in the future is important for identifying
the impact of specific symptoms in the elderly living with chronic diseases and developing
targeted strategies aimed at minimizing these symptoms. Research focused on the
relationship of HTN, HF, medications, diet and physical activity are just some of the areas
that require further investigation. Future research exploring the impact of family and
community support systems and their role in the early identification and reporting of
symptoms and the development of strategies aimed at self management is also critical.
Engaging individuals and their families in the process of self monitoring and management of
symptoms in conjunction with practitioners may also prove successful in averting
hospitalizations by providing earlier interventions. In addition, the role of access to cardiac
care, depression, anxiety, and other socio-demographic variables needs to be investigated.
Furthermore, studies examining the effect of nursing interventions aimed at improving QoL,
reducing symptoms and enhancing physical and mental health of patients living with HF
over time are recommended.
Study limitations
This research was conducted in a single outpatient cardiac center, which serves a primarily
underserved Latino population. A limitation of this the study is that most of our elderly
population resided in NYC for only part of the year and spent the winter months in the
Dominican Republic, thus resulting in 26% of our study population being unavailable for
their 6 month follow up QoL. In addition, many other factors not examined in this
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investigation may have impacted on the poor QoL results, such as limited access to clinical
care, depression, anxiety and lower socio-economic status. These factors may limit the
generalizability to other HF and cardiovascular populations.
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Relevance to clinical practice
This study highlights the need for symptom evaluation in older individuals living with
HF and other cardiovascular co-morbidities in the community. Findings of this study
indicate that QoL of symptomatic HF patients remains poor over a 6 month period, and
interventions are needed to improve QoL and decrease symptom severity. Nurses who
care for HF patients play an essential role in symptom evaluation and management and
could significantly improve overall QoL in these patients by carefully evaluating
symptomatology and testing interventions and educational programs aimed at improving
QoL.
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Summery of Self-Reported Symptoms
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Table 1
Demographic and Clinical Characteristics of the Study Population
Demographics
Number of Subjects 57
Age (years ± SD) 73 ± 6
Females 34 (60%)








Former Smokers 18 (32%)
Current Smokers 3 (5%)
BMI (Kg/m2 ± SD) 34.1 ± 8.6
Mean Systolic Blood Pressure (mmHg ± SD) 138 ± 18
Mean Diastolic Blood Pressure (mmHg ± SD) 77 ± 12
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Table 2
Norm-Based Quality of Life Profiles
N Mean Standard Deviation Range
Component Summary Measures
Physical Component Summary 55 40.82 10.56 18.95 - 60.25
Mental Component Summary 55 43.40 15.00 16.20 - 69.50
Health Domain Scales
Physical Function 57 36.82 11.42 14.94 - 57.03
Role Physical 55 39.09 18.07 17.67 - 56.85
Body Pain 56 45.20 12.09 19.86 - 62.12
General Health 57 40.67 9.87 18.61 - 60.08
Vitality 57 49.63 11.58 23.37 - 68.33
Social Function 56 41.66 12.03 13.22 - 56.85
Role Emotional 56 37.83 21.71 9.23 - 55.88
Mental Health 57 42.71 12.17 16.22 - 64.09
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Table 3


















Age, per year 1.01 0.93, 1.10 0.83
Male Gender 0.33 0.33, 0.99 0.048
Diabetes 1.93 0.67, 5.58 0.23
Hypercholesterolemia 4.60 1.36, 15.55 0.014
History of Smoking 0.32 0.10, 0.98 0.047
Severity of Last Irregular
Heart Rhythm 6.87 1.32, 35.80 0.022 16.38 1.72,155.96 0.011
Palpitations 4.38 1.03, 18.56 0.046
SOB at rest 3.69 1.05, 12.96 0.041
SOB with physical activity 2.67 0.85, 8.37 0.09
Exercise Intolerance 5.63 1.65, 19.23 0.006 7.71 1.15, 51.87 0.023
Fatigue at Rest 6.29 1.50, 26.31 0.012
Lightheadedness/Dizziness 13.42 2.61, 69.01 0.002 23.62 2.22, 250.98 0.0002
Chest Pain 4.58 1.08, 19.38 0.039
SOB=Shortness of Breath
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